| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| keynote 811 interim analysis | 0.83 | 1 | 1703 | 32 | 28 |
| keynote | 0.21 | 0.7 | 1120 | 59 | 7 |
| 811 | 0.59 | 0.9 | 2462 | 43 | 3 |
| interim | 1.33 | 0.7 | 2992 | 24 | 7 |
| analysis | 1.94 | 0.2 | 154 | 71 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| keynote-811 | 0.65 | 0.2 | 4645 | 11 |
| keynote-811 2023 | 0.87 | 0.9 | 3610 | 77 |
| keynote 811 clinical trial | 0.53 | 1 | 7525 | 48 |
| keynote-811 trial | 1.46 | 0.3 | 7563 | 61 |
| keynote-811 esmo | 1.63 | 0.5 | 7021 | 20 |
| keynote-868 | 1.23 | 0.7 | 6602 | 22 |
| keynote 811 esmo 2023 | 1.37 | 0.4 | 6668 | 90 |
| keynote 811 | 0.62 | 1 | 3066 | 62 |
| keynote 811 trial | 1.19 | 0.7 | 3213 | 10 |
| keynote 811 results | 0.17 | 0.7 | 9770 | 38 |
| keynote-811 fda | 0.56 | 0.8 | 6404 | 96 |
| keynote-811 pfs | 1.83 | 0.2 | 2098 | 23 |
| keynote-811 lancet | 1.66 | 0.5 | 5942 | 79 |
| keynote-811 overall survival | 1.39 | 0.9 | 8449 | 21 |
| keynote-811 os | 0.43 | 0.8 | 3599 | 66 |
| keynote-811 study | 0.99 | 0.7 | 5251 | 61 |
| keynote 811 schema | 0.81 | 0.8 | 6140 | 46 |
